drugset / Trial / NCT00677534

Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease

NCT00677534

Completed 7 enrolled University of Kansas
NaSingle-groupOpen-labelTreatment

Summary

The goal of this study is to evaluate the role of nutritional Vitamin D deficiency as a potential contributor to the morbidity witnessed in patients with end-stage renal disease

Timeline

Start
2008-05
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 50000 iu Oral